Subcutaneous immunoglobulin

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
14	慢性炎症性脱髄性多発神経炎／多巣性運動ニューロパチー	36

14. 慢性炎症性脱髄性多発神経炎／多巣性運動ニューロパチー

臨床試験数 : 175 / 薬物数 : 161 - (DrugBank : 41) / 標的遺伝子数 : 13 - 標的パスウェイ数 : 24

trials per page:

Showing 1 to 10 of 36 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05584631 (ClinicalTrials.gov)	October 18, 2022	10/10/2022	IVIG vs SCIG in CIDP	The Influence of Body Composition on ImmunoglobulinDisposition After Intravenous and SubcutaneousAdm ...	CIDP;Immunoglobulin Deficiency;Chronic Inflammatory Demyelinating Polyneuropathy	Drug: Intravenous immune globulin G;Drug: Subcutaneous immune globulin G	Rutgers, The State University of New Jersey	NULL	Recruiting	18 Years	65 Years	All	20	Phase 1	United States
2	NCT04589299 (ClinicalTrials.gov)	June 4, 2020	9/9/2020	Subcutaneous Immunoglobulin in De-novo CIDP (SIDEC)	Randomized, Parallel Study of SubcutaneousVersus Intravenous Immunoglobulinin Treatment-naïve Patien ...	CIDP - Chronic Inflammatory Demyelinating Polyneuropathy	Biological: Immunoglobulin	University of Aarhus	Rigshospitalet, Denmark;Aarhus University Hospital;Odense University Hospital;Aalborg University Hos ...	Recruiting	18 Years	N/A	All	60	Phase 4	Denmark
3	EUCTR2018-003592-34-DK (EUCTR)	02/08/2019	14/03/2019	Subcutaneousversus intravenous administration of immunoglobulinin newly diagnosed patients with chro ...	Subcutaneous immunoglobulinin de-novo CIDP(Randomized, parallel study of subcutaneousversus intraven ...	Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) MedDRA version: 21.1;Level: PT;Classificati ...	Trade Name: Hizentra Product Name: Hizentra INN or Proposed INN: Human ImmunoglobulinG Other descriptiv ...	Aarhus University Hospital	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	60	Phase 4	Denmark
4	EUCTR2017-002024-24-DK (EUCTR)	08/09/2017	19/06/2017	Systematic reduction in dosage of subcutanoeus immunoglobulinin patients with chronic inflammatory n ...	Randomized, cohort study of standardized reduction of subcutaneous immunoglobulintreatment in patien ...	Chronic inflammatory demyelinating polyneuroapthy MedDRA version: 20.0;Level: LLT;Classification cod ...	Trade Name: Gammanorm Product Name: Gammanorm INN or Proposed INN: Immunoglobulin Other descriptive nam ...	Aarhus Unversity Hospital	NULL	Not Recruiting			Female: yes Male: yes	60	Phase 4	Denmark
5	NCT02885259 (ClinicalTrials.gov)	September 2016	25/1/2016	HyQvia in Multifocal Motor Neuropathy	Subcutaneous Immunoglobulin With rHuPH20 in Multifocal Motor Neuropathy	Multifocal Motor Neuropathy	Drug: rHuPH20	UMC Utrecht	NULL	Not yet recruiting	18 Years	99 Years	Both	20	N/A	Netherlands
6	EUCTR2015-000828-28-NL (EUCTR)	26/07/2016	30/11/2015	Immunoglobulins given under the skin to treat patients with multifocal motor neuropathy (MMN). To in ...	Titlle: Subcutaneous immunoglobulins with rHuPH20 in multifocal motor neuropathy (MMN) It is an inte ...	Non-inferiority and safety/tolerance of Hyqvia compared to IVIg in 20 MMN patients with at least one ...	Trade Name: Hyqvia Product Name: Hyqvia	UMC Utrecht	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes		Phase 3	Netherlands
7	NCT02556437 (ClinicalTrials.gov)	June 2016	18/9/2015	Efficacy and Safety of HyQvia (Immunoglobulin10% With Recombinant Hyaluronidase) in Multifocal Motor ...	Randomized, Single-blind, Cross-over Study Investigating the Non-inferiority of Efficacy and Safety ...	Multifocal Motor Neuropathy	Drug: HyQvia;Drug: Subcuvia	Johannes Jakobsen	Baxter Healthcare Corporation	Completed	18 Years	90 Years	All	18	Phase 2	Denmark
8	EUCTR2015-003453-18-DK (EUCTR)	25/11/2015	23/09/2015	Study of the effect and safety of a new immunoglobulinpreparation (HyQvia) for subcutaneoususage in ...	A Randomized, Single-blinded, Cross-over Study investigating the Non-inferiority of Efficacy and Saf ...	Multifocal Motor Neuropathy (MMN) MedDRA version: 18.1;Level: PT;Classification code 10064135;Term: ...	Trade Name: HyQvia Product Name: HyQvia INN or Proposed INN: Human normal immunoglobulin Other descript ...	Rigshospitalet	NULL	Not Recruiting			Female: yes Male: yes	20	Phase 2	Denmark
9	EUCTR2011-003448-28-PL (EUCTR)	07/07/2015	06/05/2015	Chronic inflammatory demyelinating polyneuropathy (CIDP) and treatment with subcutaneous immunoglobu ...	Randomized, multicenter, double-blind, placebo-controlled, parallel-group phase III study to investi ...	Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) MedDRA version: 19.0;Level: PT;Classificati ...	Trade Name: Hizentra® Product Name: Hizentra® Product Code: IgPro20 INN or Proposed INN: Human normal i ...	CSL Behring GmbH	NULL	Not Recruiting			Female: yes Male: yes	350	Phase 3	United States;Estonia;Finland;Spain;Lithuania;Austria;Israel;United Kingdom;Italy;France;Czech Repub ...
10	EUCTR2011-003448-28-EE (EUCTR)	11/06/2015	14/05/2015	Chronic inflammatory demyelinating polyneuropathy (CIDP) and treatment with subcutaneous immunoglobu ...	Randomized, multicenter, double-blind, placebo-controlled, parallel-group phase III study to investi ...	Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) MedDRA version: 18.1;Level: PT;Classificati ...	Trade Name: Hizentra® Product Name: Hizentra® Product Code: IgPro20 INN or Proposed INN: Human normal i ...	CSL Behring GmbH	NULL	Not Recruiting			Female: yes Male: yes	350	Phase 3	United States;Estonia;Finland;Spain;Lithuania;Austria;Israel;Italy;United Kingdom;Czech Republic;Eur ...

First Previous1 2 3 4Next Last